These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25480581)

  • 1. Pharmacokinetics and tissue distribution of clevidipine and its metabolite in dogs and rats.
    Zhou Y; He XM; Li HQ; Ni Y; Xu MZ; Chen H; Li WY
    J Huazhong Univ Sci Technolog Med Sci; 2014 Dec; 34(6):856-860. PubMed ID: 25480581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of new calcium channel antagonist clevidipine in the rat, rabbit, and dog and pharmacokinetic/pharmacodynamic relationship in anesthetized dogs.
    Ericsson H; Tholander B; Björkman JA; Nordlander M; Regårdh CG
    Drug Metab Dispos; 1999 May; 27(5):558-64. PubMed ID: 10220482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and tissue distribution study of clevidipine and its primary metabolite H152/81 in rats.
    Wang Y; Zhao L; Li T; Yang W; Li Q; Sun L; Ding L
    Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28707762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and arteriovenous differences in clevidipine concentration following a short- and a long-term intravenous infusion in healthy volunteers.
    Ericsson H; Bredberg U; Eriksson U; Jolin-Mellgård A; Nordlander M; Regårdh CG
    Anesthesiology; 2000 Apr; 92(4):993-1001. PubMed ID: 10754618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers.
    Ericsson H; Fakt C; Jolin-Mellgård A; Nordlander M; Sohtell L; Sunzel M; Regårdh CG
    Br J Clin Pharmacol; 1999 May; 47(5):531-8. PubMed ID: 10336577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of clevidipine in healthy volunteers after intravenous infusion.
    Ericsson H; Fakt C; Höglund L; Jolin-Mellgård A; Nordlander M; Sunzel M; Regårdh CG
    Eur J Clin Pharmacol; 1999 Mar; 55(1):61-7. PubMed ID: 10206087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulatory effects and pharmacology of clevidipine, a novel ultra short acting and vascular selective calcium antagonist, in hypertensive humans.
    Schwieler JH; Ericsson H; Löfdahl P; Thulin T; Kahan T
    J Cardiovasc Pharmacol; 1999 Aug; 34(2):268-74. PubMed ID: 10445679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of clevidipine, an ultra-short acting 1,4-dihydropyridine calcium channel blocking drug, on the potency of isoflurane in rats and dogs.
    de Wolff MH; Leather HA; Wouters PF
    Eur J Anaesthesiol; 2000 Aug; 17(8):506-11. PubMed ID: 10998034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro hydrolysis rate and protein binding of clevidipine, a new ultrashort-acting calcium antagonist metabolised by esterases, in different animal species and man.
    Ericsson H; Tholander B; Regårdh CG
    Eur J Pharm Sci; 1999 Apr; 8(1):29-37. PubMed ID: 10072476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultrashort-acting calcium antagonist for rapid blood pressure control.
    Nordlander M; Sjöquist PO; Ericsson H; Rydén L
    Cardiovasc Drug Rev; 2004; 22(3):227-50. PubMed ID: 15492770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of clevidipine in dog blood by liquid chromatography tandem mass spectrometry: application to a pharmacokinetic study.
    Wei H; Gu Y; Liu Y; Chen Y; Liu C; Si D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Nov; 971():52-7. PubMed ID: 25270056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clevidipine in adult cardiac surgical patients: a dose-finding study.
    Bailey JM; Lu W; Levy JH; Ramsay JG; Shore-Lesserson L; Prielipp RC; Brister NW; Roach GW; Jolin-Mellgard A; Nordlander M
    Anesthesiology; 2002 May; 96(5):1086-94. PubMed ID: 11981147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clevidipine for controlled hypotension during spinal surgery in adolescents.
    Tobias JD
    Middle East J Anaesthesiol; 2011 Jun; 21(2):269-74. PubMed ID: 22435279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enantioselective pharmacokinetics of the enantiomers of clevidipine following intravenous infusion of the racemate in essential hypertensive patients.
    Ericsson H; Schwieler J; Lindmark BO; Löfdahl P; Thulin T; Regårdh CG
    Chirality; 2001; 13(3):130-4. PubMed ID: 11270321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytochrome p450 induction and inhibition potential of clevidipine and its primary metabolite h152/81.
    Zhang JG; Dehal SS; Ho T; Johnson J; Chandler C; Blanchard AP; Clark RJ; Crespi CL; Stresser DM; Wong J
    Drug Metab Dispos; 2006 May; 34(5):734-7. PubMed ID: 16501008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pulmonary extraction of clevidipine, a new vasodilating ultrashort-acting dihydropyridine, during cardiopulmonary bypass.
    Vuylsteke A; Milner Q; Ericsson H; Mur D; Dunning J; Jolin-Mellgård A; Nordlander M; Latimer R
    Br J Anaesth; 2000 Nov; 85(5):683-9. PubMed ID: 11094580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension.
    Smith WB; Marbury TC; Komjathy SF; Sumeray MS; Williams GC; Hu MY; Mould DR
    Eur J Clin Pharmacol; 2012 Oct; 68(10):1385-94. PubMed ID: 22457015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of clevidipine and its primary metabolite in dog plasma by liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic study.
    Zhou Y; Li H; He X; Jia M; Ni Y; Xu M; Chen H; Li W
    J Pharm Biomed Anal; 2014 Nov; 100():294-299. PubMed ID: 25194342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clevidipine: an ultra short-acting calcium channel antagonist for acute hypertension.
    Kenyon KW
    Ann Pharmacother; 2009 Jul; 43(7):1258-65. PubMed ID: 19584385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.